The diagnostic value of monitoring serum-CEA-levels in a patient undergoing therapy for a cancerous tumor is determined by obtaining cytosole from the tumor and quantitatively determining its CEA content. Preferably, the cytosole used is obtained from a portion of the tumor used for hormone receptor analysis.
展开▼